Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$1.81 USD
-0.03 (-1.85%)
Updated Aug 6, 2025 12:40 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Minerva Neurosciences, Inc has a market cap of $11.54M, which represents its share price of $1.65 multiplied by its outstanding shares number of 6.99M. As a small-cap company, NERV's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NERV 1.81 -0.03(-1.85%)
Will NERV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NERV based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NERV
Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News
Minerva Neurosciences GAAP EPS of -$0.50
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates | NERV ...
Minerva reports Q1 EPS (50c) vs ($1.13) last year